Vimovo (naproxen and esomeprazole magnesium) delayed-released tablets, marketed by AstraZeneca and Pozen Inc, are FDA approved for the symptomatic relief of arthritic conditions.
Brendan Whooley, PharmD
Advertisement
Articles by Brendan Whooley, PharmD
Advertisement
Latest Updated Articles
- Rx Product Profile: AstraZeneca and Pozen Inc's Vimovo
Published: November 18th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
2
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
3
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
4
Mind the Gap: Pharmacy’s Future as AI Evolves in Health Care
5
